RENAL CELL CARCINOMA

This early-stage study is testing a new type of personalized immune cell therapy called GCAR1 in people with advanced cancers that have stopped responding to standard treatments. The main goal is to find the safest and most effective dose of GCAR1 for patients with specific types…

This is a first-in-human study testing a new oral drug called ACC-1898 in adults with advanced solid tumors who have run out of standard treatment options. The main goals are to find a safe dose and understand how the body processes the drug. Researchers will also look for early …

This study is testing a new strategy for people with advanced kidney cancer. After initial drug treatment works to shrink or control the cancer, doctors will use targeted procedures like surgery or radiation to remove all visible tumors. The main goal is to see if patients can th…

This study is testing whether two experimental drugs, given alone or together before surgery, can safely shrink kidney tumors. The goal is to see if this pre-surgical treatment helps control the cancer. About 32 adults with a specific type of kidney cancer that can be surgically …

This study aims to see if a new type of PET scan using a tracer called 82-Rb can accurately tell how aggressive a kidney cancer tumor is before a patient has surgery. Researchers will scan 50 patients with kidney cancer and compare the scan results to the final tumor analysis aft…

This study aims to develop a non-invasive test using urine and blood samples to better identify and classify kidney cancer types. Researchers will analyze tiny particles in urine from 300 patients to find protein markers that distinguish between cancer subtypes. They will also ch…